Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Regulatory Filings Classification · 80% confidence The document is an exchange filing under SEBI LODR Regulation 29 notifying the stock exchanges of a scheduled Board meeting to consider and approve audited financial results. It does not contain actual financial statements or results, nor does it announce publication of a report; it is a general regulatory announcement/disclosure. Therefore, it falls under the catch-all Regulatory Filings category (RNS).
2026-05-23 English
Updates
Regulatory Filings
2026-05-07 English
Disruption of Operations
Regulatory Filings Classification · 95% confidence The document is an official notification addressed to stock exchanges regarding a fire incident at a subsidiary's facility. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an incident disclosure with details about the event, impact, and insurance coverage. It is not a financial report, earnings release, or management discussion. It is a regulatory announcement informing the market about a material event affecting operations. The document length is 3764 characters, relatively short and focused on disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-30 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings
2026-04-30 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-15 English
Bagging/Receiving of orders/contracts
Regulatory Filings
2026-04-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.